{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:45:27Z","timestamp":1791315927492,"version":"4.3.1"},"reference-count":58,"publisher":"American Association for the Advancement of Science (AAAS)","issue":"29","license":[{"start":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T00:00:00Z","timestamp":1594771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI150448"],"award-info":[{"award-number":["R01AI150448"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DE025447"],"award-info":[{"award-number":["R01DE025447"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R33AI116180"],"award-info":[{"award-number":["R33AI116180"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R03DE029716"],"award-info":[{"award-number":["R03DE029716"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sci. Adv."],"published-print":{"date-parts":[[2020,7,17]]},"abstract":"<jats:p>Polo-like kinase 1 (PLK1) inhibitors have the potential to eliminate the latent HIV-1 in AIDS patients.<\/jats:p>","DOI":"10.1126\/sciadv.aba1941","type":"journal-article","created":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T23:17:59Z","timestamp":1594855079000},"source":"Crossref","is-referenced-by-count":32,"title":["Inhibition of Polo-like kinase 1 (PLK1) facilitates the elimination of HIV-1 viral reservoirs in CD4\n            <sup>+<\/sup>\n            T cells ex vivo"],"prefix":"10.1126","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0814-3191","authenticated-orcid":true,"given":"Dawei","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of Pathology, Ohio State University College of Medicine, Columbus, OH 43210, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3158-673X","authenticated-orcid":true,"given":"Tsuyoshi","family":"Hayashi","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, University of Rochester School of Medicine and Dentistry, Rochester NY 14642, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Jean","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, University of Rochester School of Medicine and Dentistry, Rochester NY 14642, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9104-7730","authenticated-orcid":true,"given":"Weili","family":"Kong","sequence":"additional","affiliation":[{"name":"Department of Pathology, Ohio State University College of Medicine, Columbus, OH 43210, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3515-8417","authenticated-orcid":true,"given":"Guillaume","family":"Fiches","sequence":"additional","affiliation":[{"name":"Department of Pathology, Ohio State University College of Medicine, Columbus, OH 43210, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6028-2033","authenticated-orcid":true,"given":"Ayan","family":"Biswas","sequence":"additional","affiliation":[{"name":"Department of Pathology, Ohio State University College of Medicine, Columbus, OH 43210, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Liu","sequence":"additional","affiliation":[{"name":"Chemistry Department, College of Science and Mathematics, University of Massachusetts at Boston, Boston, MA 02125, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2907-7688","authenticated-orcid":true,"given":"Hailemichael O.","family":"Yosief","sequence":"additional","affiliation":[{"name":"Chemistry Department, College of Science and Mathematics, University of Massachusetts at Boston, Boston, MA 02125, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4529-1158","authenticated-orcid":true,"given":"Xiaofeng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Chemistry Department, College of Science and Mathematics, University of Massachusetts at Boston, Boston, MA 02125, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1422-5318","authenticated-orcid":true,"given":"Jay","family":"Bradner","sequence":"additional","affiliation":[{"name":"Novartis Institutes for BioMedical Research, Cambridge, MA 02139, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1461-3356","authenticated-orcid":true,"given":"Jun","family":"Qi","sequence":"additional","affiliation":[{"name":"Dana-Farber Cancer Institute, Department of Medicine, Harvard Medical School, Boston, MA 02115, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6097-2763","authenticated-orcid":true,"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Chemistry Department, College of Science and Mathematics, University of Massachusetts at Boston, Boston, MA 02125, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1175-5831","authenticated-orcid":true,"given":"Netty","family":"Santoso","sequence":"additional","affiliation":[{"name":"Department of Pathology, Ohio State University College of Medicine, Columbus, OH 43210, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9856-8320","authenticated-orcid":true,"given":"Jian","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Ohio State University College of Medicine, Columbus, OH 43210, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.278.5341.1291"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.24.13193"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.278.5341.1295"},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.cell.2013.09.044","article-title":"An integrated overview of HIV-1 latency","volume":"155","author":"Ruelas D. S.","year":"2013","unstructured":"D. S. Ruelas, W. C. Greene, An integrated overview of HIV-1 latency. Cell 155, 519\u2013529 (2013).","journal-title":"Cell"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature11286"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1086\/511823"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2012.01.014"},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"5094","DOI":"10.1128\/JVI.76.10.5094-5107.2002","article-title":"Death of CD4+ T-cell lines caused by human immunodeficiency virus type 1 does not depend on caspases or apoptosis","volume":"76","author":"Bolton D. L.","year":"2002","unstructured":"D. L. Bolton, B. I. Hahn, E. A. Park, L. L. Lehnhoff, F. Hornung, M. J. Lenardo, Death of CD4+ T-cell lines caused by human immunodeficiency virus type 1 does not depend on caspases or apoptosis. J. Virol. 76, 5094\u20135107 (2002).","journal-title":"J. Virol."},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1172\/JCI97555","article-title":"Latent HIV reservoirs exhibit inherent resistance to elimination by CD8+ T cells","volume":"128","author":"Huang S.-H.","year":"2018","unstructured":"S.-H. Huang, Y. Ren, A. S. Thomas, D. Chan, S. Mueller, A. R. Ward, S. Patel, C. M. Bollard, C. R. Cruz, S. Karandish, R. Truong, A. B. Macedo, A. Bosque, C. Kovacs, E. Benko, A. Piechocka-Trocha, H. Wong, E. Jeng, D. F. Nixon, Y.-C. Ho, R. F. Siliciano, B. D. Walker, R. B. Jones, Latent HIV reservoirs exhibit inherent resistance to elimination by CD8+ T cells. J. Clin. Invest. 128, 876\u2013889 (2018).","journal-title":"J. Clin. Invest."},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41590-018-0085-3","article-title":"Resistance of HIV-infected macrophages to CD8+ T lymphocyte-mediated killing drives activation of the immune system","volume":"19","author":"Clayton K. L.","year":"2018","unstructured":"K. L. Clayton, D. R. Collins, J. Lengieza, M. Ghebremichael, F. Dotiwala, J. Lieberman, B. D. Walker, Resistance of HIV-infected macrophages to CD8+ T lymphocyte-mediated killing drives activation of the immune system. Nat. Immunol. 19, 475\u2013486 (2018).","journal-title":"Nat. Immunol."},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"e00012-17","DOI":"10.1128\/JVI.00012-17","article-title":"Maintenance of the HIV reservoir is antagonized by selective BCL2 inhibition","volume":"91","author":"Cummins N. W.","year":"2017","unstructured":"N. W. Cummins, A. M. Sainski-Nguyen, S. Natesampillai, F. Aboulnasr, S. Kaufmann, A. D. Badley, Maintenance of the HIV reservoir is antagonized by selective BCL2 inhibition. J. Virol. 91, e00012-17 (2017).","journal-title":"J. Virol."},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.immuni.2018.04.004","article-title":"Anti-apoptotic protein BIRC5 maintains survival of HIV-1-infected CD4+ T cells","volume":"48","author":"Kuo H.-H.","year":"2018","unstructured":"H.-H. Kuo, R. Ahmad, G. Q. Lee, C. Gao, H.-R. Chen, Z. Ouyang, M. J. Szucs, D. Kim, A. Tsibris, T.-W. Chun, E. Battivelli, E. Verdin, E. S. Rosenberg, S. A. Carr, X. G. Yu, M. Lichterfeld, Anti-apoptotic protein BIRC5 maintains survival of HIV-1-infected CD4+ T cells. Immunity 48, 1183\u20131194.e5 (2018).","journal-title":"Immunity"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2018.09.007"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature16933"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2007.01.003"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrm3819"},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"22592","DOI":"10.1074\/jbc.M109.065003","article-title":"Liaisons between survivin and Plk1 during cell division and cell death","volume":"285","author":"Colnaghi R.","year":"2010","unstructured":"R. Colnaghi, S. P. Wheatley, Liaisons between survivin and Plk1 during cell division and cell death. J. Biol. Chem. 285, 22592\u201322604 (2010).","journal-title":"J. Biol. Chem."},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1053\/j.gastro.2011.11.023","article-title":"Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells","volume":"142","author":"Zhang Y.","year":"2012","unstructured":"Y. Zhang, X.-L. Du, C.-J. Wang, D.-C. Lin, X. Ruan, Y.-B. Feng, Y.-Q. Huo, H. Peng, J.-L. Cui, T.-T. Zhang, Y.-Q. Wang, H. Zhang, Q.-M. Zhan, M.-R. Wang, Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells. Gastroenterology 142, 521\u2013530.e3 (2012).","journal-title":"Gastroenterology"},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"5517","DOI":"10.1172\/JCI122533","article-title":"PLK1 stabilizes a MYC-dependent kinase network in aggressive B cell lymphomas","volume":"128","author":"Ren Y.","year":"2018","unstructured":"Y. Ren, C. Bi, X. Zhao, T. Lwin, C. Wang, J. Yuan, A. S. Silva, B. D. Shah, B. Fang, T. Li, J. M. Koomen, H. Jiang, J. C. Chavez, L. V. Pham, P. R. Sudalagunta, L. Wan, X. Wang, W. S. Dalton, L. C. Moscinski, K. H. Shain, J. Vose, J. L. Cleveland, E. M. Sotomayor, K. Fu, J. Tao, PLK1 stabilizes a MYC-dependent kinase network in aggressive B cell lymphomas. J. Clin. Invest. 128, 5517\u20135530 (2018).","journal-title":"J. Clin. Invest."},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1031523100"},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"25549","DOI":"10.1074\/jbc.M314182200","article-title":"Polo-like kinase 1 (Plk1) inhibits p53 function by physical interaction and phosphorylation","volume":"279","author":"Ando K.","year":"2004","unstructured":"K. Ando, T. Ozaki, H. Yamamoto, K. Furuya, M. Hosoda, S. Hayashi, M. Fukuzawa, A. Nakagawara, Polo-like kinase 1 (Plk1) inhibits p53 function by physical interaction and phosphorylation. J. Biol. Chem. 279, 25549\u201325561 (2004).","journal-title":"J. Biol. Chem."},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"8555","DOI":"10.1074\/jbc.M710608200","article-title":"Inhibitory role of Plk1 in the regulation of p73-dependent apoptosis through physical interaction and phosphorylation","volume":"283","author":"Koida N.","year":"2008","unstructured":"N. Koida, T. Ozaki, H. Yamamoto, S. Ono, T. Koda, K. Ando, R. Okoshi, T. Kamijo, K. Omura, A. Nakagawara, Inhibitory role of Plk1 in the regulation of p73-dependent apoptosis through physical interaction and phosphorylation. J. Biol. Chem. 283, 8555\u20138563 (2008).","journal-title":"J. Biol. Chem."},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"14542","DOI":"10.1073\/pnas.0904229106","article-title":"Polo-like kinases mediate cell survival in mitochondrial dysfunction","volume":"106","author":"Matsumoto T.","year":"2009","unstructured":"T. Matsumoto, P.-Y. Wang, W. Ma, H. J. Sung, S. Matoba, P. M. Hwang, Polo-like kinases mediate cell survival in mitochondrial dysfunction. Proc. Natl. Acad. Sci. U.S.A. 106, 14542\u201314546 (2009).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2964"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.26.6.2093-2108.2006"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3184"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-07-168393"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003834"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005066"},{"key":"e_1_3_2_31_2","doi-asserted-by":"crossref","first-page":"25605","DOI":"10.1074\/jbc.M103244200","article-title":"HIV-1 Nef promotes survival of myeloid cells by a Stat3-dependent pathway","volume":"276","author":"Briggs S. D.","year":"2001","unstructured":"S. D. Briggs, B. Scholtz, J. M. Jacque, S. Swingler, M. Stevenson, T. E. Smithgall, HIV-1 Nef promotes survival of myeloid cells by a Stat3-dependent pathway. J. Biol. Chem. 276, 25605\u201325611 (2001).","journal-title":"J. Biol. Chem."},{"key":"e_1_3_2_32_2","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1038\/ncomms2879","article-title":"PI 3-kinase-dependent phosphorylation of Plk1-Ser99 promotes association with 14-3-3\u03b3 and is required for metaphase-anaphase transition","volume":"4","author":"Kasahara K.","year":"2013","unstructured":"K. Kasahara, H. Goto, I. Izawa, T. Kiyono, N. Watanabe, S. Elowe, E. A. Nigg, M. Inagaki, PI 3-kinase-dependent phosphorylation of Plk1-Ser99 promotes association with 14-3-3\u03b3 and is required for metaphase-anaphase transition. Nat. Commun. 4, 1882 (2013).","journal-title":"Nat. Commun."},{"key":"e_1_3_2_33_2","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.1128\/MCB.00814-14","article-title":"Plk1 phosphorylation of PTEN causes a tumor-promoting metabolic state","volume":"34","author":"Li Z.","year":"2014","unstructured":"Z. Li, J. Li, P. Bi, Y. Lu, G. Burcham, B. D. Elzey, T. Ratliff, S. F. Konieczny, N. Ahmad, S. Kuang, X. Liu, Plk1 phosphorylation of PTEN causes a tumor-promoting metabolic state. Mol. Cell. Biol. 34, 3642\u20133661 (2014).","journal-title":"Mol. Cell. Biol."},{"key":"e_1_3_2_34_2","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.canlet.2018.09.024","article-title":"PI3K blockage synergizes with PLK1 inhibition preventing endoreduplication and enhancing apoptosis in anaplastic thyroid cancer","volume":"439","author":"De Martino D.","year":"2018","unstructured":"D. De Martino, E. Yilmaz, A. Orlacchio, M. Ranieri, K. Zhao, A. D. Cristofano, PI3K blockage synergizes with PLK1 inhibition preventing endoreduplication and enhancing apoptosis in anaplastic thyroid cancer. Cancer Lett. 439, 56\u201365 (2018).","journal-title":"Cancer Lett."},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1157425"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M116.066019"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.10.085"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200108016"},{"key":"e_1_3_2_39_2","doi-asserted-by":"crossref","first-page":"4032","DOI":"10.1128\/JVI.03179-15","article-title":"Prime, shock, and kill: Priming CD4 T cells from HIV patients with a BCL-2 antagonist before HIV reactivation reduces HIV reservoir size","volume":"90","author":"Cummins N. W.","year":"2016","unstructured":"N. W. Cummins, A. M. Sainski, H. Dai, S. Natesampillai, Y. P. Pang, G. D. Bren, M. C. M. de Araujo Correia, R. Sampath, S. A. Rizza, D. O'Brien, J. D. Yao, S. H. Kaufmann, A. D. Badley, Prime, shock, and kill: Priming CD4 T cells from HIV patients with a BCL-2 antagonist before HIV reactivation reduces HIV reservoir size. J. Virol. 90, 4032\u20134048 (2016).","journal-title":"J. Virol."},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4347"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003398"},{"key":"e_1_3_2_42_2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nchembio.1471","article-title":"Dual kinase-bromodomain inhibitors for rationally designed polypharmacology","volume":"10","author":"Ciceri P.","year":"2014","unstructured":"P. Ciceri, S. M\u00fcller, A. O'Mahony, O. Fedorov, P. Filippakopoulos, J. P. Hunt, E. A. Lasater, G. Pallares, S. Picaud, C. Wells, S. Martin, L. M. Wodicka, N. P. Shah, D. K. Treiber, S. Knapp, Dual kinase-bromodomain inhibitors for rationally designed polypharmacology. Nat. Chem. Biol. 10, 305\u2013312 (2014).","journal-title":"Nat. Chem. Biol."},{"key":"e_1_3_2_43_2","doi-asserted-by":"crossref","first-page":"7785","DOI":"10.1021\/acs.jmedchem.8b00765","article-title":"Structure-guided design and development of potent and selective dual bromodomain 4 (BRD4)\/polo-like kinase 1 (PLK1) inhibitors","volume":"61","author":"Liu S.","year":"2018","unstructured":"S. Liu, H. O. Yosief, L. Dai, H. Huang, G. Dhawan, X. Zhang, A. M. Muthengi, J. Roberts, D. L. Buckley, J. A. Perry, L. Wu, J. E. Bradner, J. Qi, W. Zhang, Structure-guided design and development of potent and selective dual bromodomain 4 (BRD4)\/polo-like kinase 1 (PLK1) inhibitors. J. Med. Chem. 61, 7785\u20137795 (2018).","journal-title":"J. Med. Chem."},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0802905"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1027-4"},{"key":"e_1_3_2_46_2","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/nm.4124","article-title":"Stimulating the RIG-I pathway to kill cells in the latent HIV reservoir following viral reactivation","volume":"22","author":"Li P.","year":"2016","unstructured":"P. Li, P. Kaiser, H. W. Lampiris, P. Kim, S. A. Yukl, D. V. Havlir, W. C. Greene, J. K. Wong, Stimulating the RIG-I pathway to kill cells in the latent HIV reservoir following viral reactivation. Nat. Med. 22, 807\u2013811 (2016).","journal-title":"Nat. Med."},{"key":"e_1_3_2_47_2","doi-asserted-by":"crossref","first-page":"e01368-17","DOI":"10.1128\/AAC.01368-17","article-title":"Evaluation of the innate immune modulator acitretin as a strategy to clear the HIV reservoir","volume":"61","author":"Garcia-Vidal E.","year":"2017","unstructured":"E. Garcia-Vidal, M. Castellv\u00ed, M. Pujantell, R. Badia, A. Jou, L. Gomez, T. Puig, B. Clotet, E. Ballana, E. Riveira-Mu\u00f1oz, J. A. Est\u00e9, Evaluation of the innate immune modulator acitretin as a strategy to clear the HIV reservoir. Antimicrob. Agents Chemother. 61, e01368-17 (2017).","journal-title":"Antimicrob. Agents Chemother."},{"key":"e_1_3_2_48_2","doi-asserted-by":"crossref","first-page":"e122673","DOI":"10.1172\/jci.insight.122673","article-title":"Dual TLR2 and TLR7 agonists as HIV latency-reversing agents","volume":"3","author":"Macedo A. B.","year":"2018","unstructured":"A. B. Macedo, C. L. Novis, C. M. De Assis, E. S. Sorensen, P. Moszczynski, S.-H. Huang, Y. Ren, A. M. Spivak, R. B. Jones, V. Planelles, A. Bosque, Dual TLR2 and TLR7 agonists as HIV latency-reversing agents. JCI Insight 3, e122673 (2018).","journal-title":"JCI Insight"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-1951-3"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI92684"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-0898-8"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005472"},{"key":"e_1_3_2_53_2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0140-6736(07)61050-2","article-title":"Incidence of cancers in people with HIV\/AIDS compared with immunosuppressed transplant recipients: A meta-analysis","volume":"370","author":"Grulich A. E.","year":"2007","unstructured":"A. E. Grulich, M. T. van Leeuwen, M. O. Falster, C. M. Vajdic, Incidence of cancers in people with HIV\/AIDS compared with immunosuppressed transplant recipients: A meta-analysis. Lancet 370, 59\u201367 (2007).","journal-title":"Lancet"},{"key":"e_1_3_2_54_2","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s11908-014-0406-0","article-title":"Non-AIDS-defining malignancies in the HIV-infected population","volume":"16","author":"Wang C.-C.","year":"2014","unstructured":"C.-C. Wang, M. J. Silverberg, D. I. Abrams, Non-AIDS-defining malignancies in the HIV-infected population. Curr. Infect. Dis. Rep. 16, 406 (2014).","journal-title":"Curr. Infect. Dis. Rep."},{"key":"e_1_3_2_55_2","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/sj.onc.1208272","article-title":"Polo-like kinases (Plks) and cancer","volume":"24","author":"Takai N.","year":"2005","unstructured":"N. Takai, R. Hamanaka, J. Yoshimatsu, I. Miyakawa, Polo-like kinases (Plks) and cancer. Oncogene 24, 287\u2013291 (2005).","journal-title":"Oncogene"},{"key":"e_1_3_2_56_2","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1745-7254.2008.00750.x","article-title":"Expression of PLK1 and survivin in non-Hodgkin\u2019s lymphoma treated with CHOP","volume":"29","author":"Liu L.","year":"2008","unstructured":"L. Liu, M. Zhang, P. Zou, Expression of PLK1 and survivin in non-Hodgkin\u2019s lymphoma treated with CHOP. Acta Pharmacol. Sin. 29, 371\u2013375 (2008).","journal-title":"Acta Pharmacol. Sin."},{"key":"e_1_3_2_57_2","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.3389\/fmicb.2017.02007","article-title":"Curaxin CBL0100 blocks HIV-1 replication and reactivation through inhibition of viral transcriptional elongation","volume":"8","author":"Jean M. J.","year":"2017","unstructured":"M. J. Jean, T. Hayashi, H. Huang, J. Brennan, S. Simpson, A. Purmal, K. Gurova, M. C. Keefer, J. J. Kobie, N. G. Santoso, J. Zhu, Curaxin CBL0100 blocks HIV-1 replication and reactivation through inhibition of viral transcriptional elongation. Front. Microbiol. 8, 2007 (2017).","journal-title":"Front. Microbiol."},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1019736108"},{"key":"e_1_3_2_59_2","doi-asserted-by":"crossref","first-page":"ofv123","DOI":"10.1093\/ofid\/ofv123","article-title":"Designing and interpreting limiting dilution assays: General principles and applications to the latent reservoir for human immunodeficiency virus-1","volume":"2","author":"Rosenbloom D. I.","year":"2015","unstructured":"D. I. Rosenbloom, O. Elliott, A. L. Hill, T. J. Henrich, J. M. Siliciano, R. F. Siliciano, Designing and interpreting limiting dilution assays: General principles and applications to the latent reservoir for human immunodeficiency virus-1. Open Forum Infect. Dis. 2, ofv123 (2015).","journal-title":"Open Forum Infect. Dis."}],"container-title":["Science Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1126\/sciadv.aba1941","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.science.org\/doi\/pdf\/10.1126\/sciadv.aba1941","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T17:31:23Z","timestamp":1704821483000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.science.org\/doi\/10.1126\/sciadv.aba1941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,17]]},"references-count":58,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2020,7,17]]}},"alternative-id":["10.1126\/sciadv.aba1941"],"URL":"https:\/\/doi.org\/10.1126\/sciadv.aba1941","relation":{},"ISSN":["2375-2548"],"issn-type":[{"value":"2375-2548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,17]]},"article-number":"eaba1941"}}